Cargando…

An ALARMINg Type 2 Response in Cystic Fibrosis—The Key to Understanding ABPA?

Detalles Bibliográficos
Autores principales:	Bojanowski, Christine M., Bitoun, Jacob P., Kolls, Jay K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263133/ https://www.ncbi.nlm.nih.gov/pubmed/37023264 http://dx.doi.org/10.1164/rccm.202303-0580ED

Ejemplares similares

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA
por: Kurup, Viswanath P, et al.
Publicado: (2006)

A case report of ABPA, cystic fibrosis and asthma treated with omalizumab
por: Mazza, JA, et al.
Publicado: (2015)

Spelunking in Sputum: Single-Cell RNA Sequencing Sheds New Insights into Cystic Fibrosis
por: Iwanaga, Naoki, et al.
Publicado: (2020)

Bronchial asthma with ABPA presenting as PTE
por: Azad, Chandrika, et al.
Publicado: (2013)

Review of current and future therapeutics in ABPA
por: Lewington-Gower, Elisa, et al.
Publicado: (2021)

Comprehensive transcriptome analysis of peripheral blood unravels key lncRNAs implicated in ABPA and asthma
por: Huang, Chen, et al.
Publicado: (2021)

Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
por: Michel, Moïse, et al.
Publicado: (2022)

Aspergillus march: from ABPA to aspergilloma to subacute invasive aspergillosis
por: Dogra, Vikas, et al.
Publicado: (2016)

Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?
por: Agarwal, Ritesh, et al.
Publicado: (2021)

Pulmonary actinomycosis and polymicrobial empyema in a patient with ABPA and bronchocoele
por: Tu, Jacky, et al.
Publicado: (2022)

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
por: Mümmler, Carlo, et al.
Publicado: (2020)

Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?”
por: Matsuura, Hiroaki, et al.
Publicado: (2021)

The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA—A Case Series
por: O’Reilly, Aoife, et al.
Publicado: (2021)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
por: De Rose, Virginia, et al.
Publicado: (2018)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

The overcrowded curriculum is alarming
por: D’Eon, Marcel F
Publicado: (2023)

The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis
por: Lu, Hai‐Wen, et al.
Publicado: (2019)

Allergic bronchopulmonary aspergillosis (ABPA) in an atopic patient with difficult-to-expectorate airway secretions
por: Joest, Marcus
Publicado: (2021)

Immune Response in Cystic Fibrosis: Interplay between the Host and Microbes
por: Boutin, Sébastien, et al.
Publicado: (2023)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Update on Key Emerging Challenges in Cystic Fibrosis
por: Jennings, Mark T., et al.
Publicado: (2014)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Systems serology in cystic fibrosis: Anti-Pseudomonas IgG1 responses and reduced lung function
por: Lu, Shiping, et al.
Publicado: (2023)

Eosinophils may serve as CEA-secreting cells for allergic bronchopulmonary aspergillosis (ABPA) patients
por: Yang, Yanfei, et al.
Publicado: (2021)

Misdiagnosis of persistent asthma of a patient suffering from acute bronchopulmonary aspergillosis (ABPA)
por: Abuzneid, Yousef S., et al.
Publicado: (2021)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

The Impact of COVID-19 in Cystic Fibrosis
por: Flume, Patrick A., et al.
Publicado: (2022)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Understanding the complex host response in sepsis: is diabetes the key?
por: Mayr, Florian B., et al.
Publicado: (2016)

We View with Alarm
Publicado: (1892)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p0244cp0sdetgjbspd40qc6ocd